Background: The APOA1/C3/A4/A5 gene cluster encodes important regulators of
associated with altered triglycerides (4, (13) (14) (15) (16) . The three SNPs analyzed here were also previously studied: APOC3 -2886T/G, reported as −2854T/G, has been associated with altered fasting triglycerides (17) . APOC3 -640, rs2542052, has been described as -641C/A and associated with longevity and HDL levels (18, 19) , although other authors did not replicate the findings (18) . The minor allele of the APOC3 synonymous G34G variant (rs4520, also known as 1100C>T) has been widely studied, first reported to associate with elevated triglyceride levels (20) . Although these three SNPs were previously reported as putative functional SNPs, their influence in the postprandial situation has not been tested.
Apolipoprotein A-IV (APOA4) influences dietary fat absorption and chylomicron synthesis (4) , modulates the activation of LPL by Apolipoprotein C-II (21) and activates lecithin-cholesterol acyltransferase (22) . Previous information on altered postprandial lipemia depending on APOA4 SNPs has been published. The carriers of the minor allele of the Gln360His variant have an increased postprandial lipemia when exposed to a saturated fatty acid-rich diet, as they have increased peaks of small TRL-CHOL, small TRL-TG and large TRL-TG particles (23) , but, interestingly, in a case control study (offspring of fathers who suffered a myocardial infarction before the age of 55 years VS controls), the subgroup of controls who were carriers of the minor allele of this SNP presented lower BMIs, fasting cholesterol and TG concentrations. Furthermore, and after consumption of an oral fat load, obese participants of this study (but not the rest of the population), who were carriers of the minor allele, had significantly reduced postprandial lipemia (24) . Carriers of the rare allele of Thr347Ser show a lower postprandial response in the TG levels of TRL remnants (25) . APOA4 N147S has been linked to fasting triglyceride levels, but its importance on postprandial lipemia remains unknown (26) .
APO4T29T is a synonymous SNP located in the coding region of APOA4 which has not been previously tested as a functional SNP. Both because of its location and its being a synonymous SNP, we selected it for the present study.
Apolipoprotein V (APOA5) regulates TG metabolism by mechanisms that include hepatic VLDL and TRL catabolism (27) . Some variations in this gene (T-1131C and Ser19Trp) have been linked to altered fasting and postprandial TG (28, 29) . Haplotype analysis based on five polymorphisms (1131T>C, c.-3A>G, c.56C>G, IVS3+476G>A, by guest, on October 1, 2017 www.jlr.org c.1259T>C) in the APOA5 gene define three common haplotypes (APOA5*1, APOA5*2 and APOA5*3) (30) . APOA5*2 and APOA5*3 carriers have a higher postprandial response, higher area under the curve of total plasma TG, large TRL-TG, small TRL-TG, small TRL-CHOL and large TRL-CHOL than subjects with the APOA5*1 haplotype(31).
In the intergenic region between APOA4 and APOA5 resides A4A5_inter (rs1263177) SNP. Although its location suggests it might be a non-functional variant, an association of this SNP with altered TG levels has been reported. Talmud, et al.(32) , found a lower level of fasting TG in homozygotes for the minor allele compared with common allele homozygotes. Furthermore, the same SNP was further studied by the same group, but interestingly, this time the results were distinct: while the SNP did not affect the postprandial lipids after an oral fat tolerance test, homozygosity for the rare allele was associated with higher waist to hip ratio, systolic blood pressure and AUC and peak of insulin after an oral glucose tolerance test (33) . These contradicting reports and the repetitive positive phenotype-genotype results made this SNP a good candidate for eventual study in lipid metabolism.
The precise role of the regulatory elements present throughout the APOA1/C3/A4/A5 cluster is complex and incomplete, with numerous interactions with different transcription factors described in the immediate upstream regions of each gene (8) . Both the study of the regulatory elements in the cluster region as well as the significance of the tight linkage disequilibrium (LD) between the SNPs in this region (highly influenced by the population under study) remain an active field of research (34) (35) (36) (37) .
The specific purpose of this study was to further characterize SNPs in the APOA1/C3/A4/A5 cluster, describing their relationship with postprandial lipemia. With this aim, we genotyped three SNPs at APOA1 (all in the promoter region: APOA1 -2630, APOA1 -2803, APOA1 -3012), three at APOC3 (APOC3 -2886, APOC3 -640, APOC3
MATERIALS AND METHODS

Subjects
Eighty-eight healthy men aged 18 to 33 years were enrolled in two studies conducted by the Lipids and Atherosclerosis Research Unit at Reina Sofia University Hospital. The first study included 50 participants, whereas the second study included 38 patients. All tests were performed using the same methodology, as described below. We included only young normolipemic APOE E3/E3 males in order to avoid possible effects of different APOE isoforms or gender. Other results of these studies have been published elsewhere (10, 23, 25, 28, 31, (38) (39) (40) (41) (42) (43) (44) (45) . No participants had diabetes or liver, renal or thyroid disease, nor were they taking any medication. Anthropometric measures (weight, height, and body mass index) and blood pressure were assessed and all subjects were encouraged to maintain regular lifestyle and levels of physical activity. All volunteers had plasma cholesterol and triacylglycerol concentrations below 200 mg/dl. Baseline characteristics of the participants are summarized in Table 1 The studies in which these participants were enrolled were approved by the Ethics Committee for Clinical Investigations of the Reina Sofía University Hospital in Cordoba, and participants previously signed an informed content to join the study.
Study design
After an overnight, 12-h fast, subjects were given a fatty meal enriched with 60 were assessed for a change in codon usage frequency. Incorporation of a rare or common codon can affect protein secondary structure (48) . Reference genomic sequence of SNPs in gene control regions was analyzed with MAPPER to determine allele-specific transcription factor binding sites (49) . Six of the selected SNPs map upstream of corresponding genes, in regions likely to control transcription and are listed in Supplemental Table 1 (Table S1 ) with a "minus" -designation. The SNP intergenic to APOA4 and APOA5(32) maps 28 kbp upstream of APOA5 and 706 bp downstream of the end site of APOA4 transcription. SNPs were genotyped using the Applied Biosystems TaqMan assay (45, 50, 51) . Allele discrimination was performed on PCR products.
Fluorescence data were collected by a 7900 Sequence Detection System (Applied Biosystems) (50) .
Lipoprotein separation and lipid analysis:
Large and small TRL were manually extracted after centrifugation in subdued light as previously described, and samples were stored at -70ºC until analyzed (45) . Total cholestyerol (CHOL) and triglycerides (TG) in plasma and lipoprotein fractions were assayed by enzymatic procedures (52, 53) . APOA1 and APOB were determined by turbidimetry (54) . HDL-C was measured by analyzing the supernatant obtained following precipitation of a plasma aliquot with dextran sulfate-Mg 2+ , as described by Warnick et al. (55) . LDL-C levels were estimated using the Friedewald formula, based on the CHOL, TG, and HDL-C values (56) .
Statistical analysis
Genotypic analysis:
Linkage disequilibrium (LD) was tested using Helix-Tree software pertinent tools Bonferroni or Games-Howell adjustments were used, depending on Levene's test for homogeneity of variances. If the variances were homogeneous, the method for correction was Bonferroni adjustment, while non-homogeneous variances called for using the Games-Howell method. Repeated-measures ANOVA was also used for both the overall gene influence (global ANOVA, p for gene influence), the kinetics of the response (p for time), and the interaction of both factors (time*gene). When statistical differences were found in the repeated measured ANOVA, a multiple comparisons test adjusted by Bonferroni's rule was applied to identify differences among the genetic isoforms on each time-point of extraction. When minor allele homozygotes were less than 5% or a dominant effect of the allele was inferred, we also studied the stratified data of carriers of the mutant allele versus the homozygotes for the common allele. As a multivariate approach to test the independency of the influences of the SNPs in the postprandial lipids, when two or more SNPs showed influence on the same lipid parameter, these SNPs were subsequently entered as fixed factors in pairwise combinations into an ANOVA to determine if any non-independent genetic effects were present (age and BMI were included as covariates). Time to maximum peak of TG and large TRL-TG was assessed as the central point at which the sum of three consecutive time-points values was maximum. A value of less than 0.05 was considered significant. All data presented in the text and tables are expressed as mean ± S.E unless otherwise specified. SPSS 15.0 for Windows (SPSS Inc., Chicago, IL, USA) was used for statistical comparisons.
RESULTS
The C allele of APOC3 G34G is part of a GGC codon for glycine and is found in 22. Table 2 .
Baseline characteristics of the participants of the study are summarized in Table 1 .
Data on genotype distribution and Hardy-Weinberg equilibrium are shown in Table 2 .
The LD analysis showed the existence of LD between many of the SNPs present in this influence of the SNPs on postprandial lipid levels is described below, and is summarized in Table 4 .
Apolipoprotein A-I gene (APOA1)
APOA1 -2803 AA (minor allele homozygotes) showed a smaller postprandial AUC of TG, large TRL-TG and APOB than GA (p<0.001 for TG and large TRL-TG and p=0.013
for APOB) and GG (p=0.005, p=0.012 and p=0.031, respectively) ( Table 4) Table 4 .
Apolipoprotein C-III gene (APOC3)
We found no influence of these APOC3 SNPs on the AUCs of the different lipid
fractions. An early B-cell factor 1 (EBF1) binding site at -640 was predicted only for the C allele ( Figure S4 ). The EBF1 transcription factor is moderately expressed in all 75 human tissues tested but is highly expressed in human adipocytes, testis germ cells, uterus and B cells (57) . Repeated-measures ANOVA of APOC3 -640 revealed a gene*time interaction, (p for interaction =0.004 for TG and 0.001 for large-TRL TG).
The maximum peak of TG was observed at the third postprandial hour (3.35±0.11 hours)
for CC and CA and at the fourth hour for AA (mean 4.03±0.31 hours). This difference was statistically significant in an ANOVA test between CC/CA VS AA (p=0.047). The maximum peak for large-TRL TG was also retarded in AA homozygotes (AA 4.6±0,13
hours VS CC/CA 3.4±0.40 hours; p=0.01). However, the multiple-comparisons test did not find statistically significant differences in the means of the TG concentrations at any time-points (Figure 1 ).
Apolipoprotein A-IV gene (APOA4)
Heterozygotes for APOA4 N147S and T29T showed a smaller AUC of APOA1 levels than homozygotes for the common allele (APOA4 N147S GG 69531±1562 vs GA 63734±2006, p=0.040; T29T AA 69401±1709 vs AG 64408±1930, p=0.027). Repeatedmeasures ANOVA showed a higher concentration of APOA1 in homozygotes for the common allele vs heterozygotes for the two APOA4 SNPs (p=0.023 for APOA4 N147S and p=0.047 for T29T). Differences were observed at every time-point from baseline to the eleventh hour except at 6 hours (p=0.102) for APOA4 N147S (Figure S5 ), and at baseline and the first five time-points for T29T ( Figure S6 ).
APOA4/APOA5 intergenic region
TT individuals of A4A5_inter (homozygotes for the common allele) showed a larger AUC of total TG and large TRL-CHOL than heterozygotes (p= 0.047 and p=0.001), and a larger AUC of CHOL and APOB compared to CC group (p=0.022 and p=0.046 respectively) ( Table 4 ). In view of the possibility of a dominant allele effect, we stratified the sample into carriers of the minor allele (groups TC and CC) and homozygotes for the common allele (group TT). Subsequent analyses showed a striking effect of the presence of the minor allele, as it provoked lower TG (p=0.009), CHOL (p=0.042), large-TRL-TG (p=0,045) and large-TRL-CHOL (p=0.001) values (Figure 2 ).
Repeated-measures ANOVA of the means showed larger CHOL in TT compared to CC subjects (p=0.048). These changes were observed at baseline and at every time-point except at 8.5 hours ( Figure S7 ). TG levels were higher in TT compared to TC (p=0.019), and there was a similar but not significant trend when TT was compared to CC. The multiple-comparisons test resulted in a significant higher mean TG at baseline and at the The multiple-comparisons test showed differences at every time-point for TC vs TT except at hour 3 and at hours 1, 2 and 8.5 for CC vs TT ( Figure S11 ).
Multivariate analysis.
APOA1 -2803 and A4A5_inter were entered in a model to test for non-independent gene effects in AUC of TG in a model that also included BMI and age. As expected, the To the best of our knowledge, the influence of APOA1 -2803 in the postprandial lipid metabolism has never been studied. We observed that homozygotes for the minor allele displayed a lesser degree of postprandial lipemia as compared to other groups. APOA1
protein is mainly present in HDL-cholesterol. However, APOA1 is also present on the surface of nascent chylomicrons and it is in this capacity that the influence of the APOA1 -2803 variant on postprandial lipemia may be mediated by altered levels of APOA1 present on the surface of large TRL. This is supported by the fact that, despite the major influence that we have identified on TG and large TRL-TG, we found no effect of this SNP on postprandial metabolism of molecules, such as small TRL, whose surfaces do not contain APOA1. On the other hand, it appears that the modifications induced by this SNP might be due to an altered APOA1 function rather than on APOA1 transcription rate, because the presence of the minor allele did not influence APOA1 or HDL-C concentrations. The suggestion that the -2803 A/G polymorphism is in strong LD with an untested functional variant is strengthened by the lack of evidence for transcription factor binding at this position.
The APOC3 polymorphism at -640 has previously been studied in the Ashkenazi people (19) , in whom homozygosity for the minor allele was over-represented in a cohort of older persons. Novelli et al, eventually, tested the relationship between longevity and the presence of this SNP (among other candidate SNPs) in a cohort of elderly American
Caucasians, but, in this case, this APOC3 SNP was not over-represented (18) . Our study did not find any difference in the AUC of the various lipid fractions during lipemia, but a different kinetics, as the times to maximum peak of TG and large TRL-TG were delayed in subjects homozygous for the minor allele (AA). Prolonged lipemia has been linked to accelerated atherosclerosis(1), although this may not be the case, as the AUC was not affected by the presence of the minor allele. However, the different kinetics and the possible link to an increased presence of the homozygote genotype in centenarians is an interesting combination, which should be investigated further.
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